Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.4%

3 terminated/withdrawn out of 216 trials

Success Rate

87.0%

+0.5% vs industry average

Late-Stage Pipeline

14%

30 trials in Phase 3/4

Results Transparency

0%

0 of 20 completed trials have results

Key Signals

58 recruiting

Enrollment Performance

Analytics

N/A
70(46.1%)
Phase 2
39(25.7%)
Phase 4
15(9.9%)
Phase 3
15(9.9%)
Early Phase 1
7(4.6%)
Phase 1
6(3.9%)
152Total
N/A(70)
Phase 2(39)
Phase 4(15)
Phase 3(15)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (216)

Showing 20 of 216 trials
NCT07632677Recruiting

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Role: collaborator

NCT05828953Phase 2Active Not Recruiting

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Role: lead

NCT05356104Phase 2Recruiting

GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)

Role: collaborator

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT06012760Not ApplicableRecruiting

The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion

Role: collaborator

NCT07613437Phase 2Not Yet Recruiting

GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial

Role: collaborator

NCT06544083Recruiting

Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

Role: collaborator

NCT07604896Phase 4Recruiting

Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs

Role: lead

NCT07604350Phase 3Not Yet Recruiting

Edaravone Dexborneol for Post-Stroke Epilepsy

Role: lead

NCT05572957Not ApplicableActive Not Recruiting

LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB

Role: collaborator

NCT04624763Not ApplicableActive Not Recruiting

Protection of Cardiac Function With Left Bundle Branch Pacing in Patients With Atrioventricular Block

Role: collaborator

NCT07586384Not ApplicableRecruiting

Single-port Versus Conventional Laparoscopic Surgery for Radical Proximal Gastric Cancer: A Randomized Controlled Trial

Role: lead

NCT07583589Phase 2Not Yet Recruiting

Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Role: lead

NCT05491811Phase 2Active Not Recruiting

Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation

Role: collaborator

NCT07095023Not ApplicableRecruiting

Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer

Role: collaborator

NCT07548281Not ApplicableNot Yet Recruiting

Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions

Role: collaborator

NCT05698550Not ApplicableCompleted

The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET

Role: collaborator

NCT06968936Not ApplicableRecruiting

Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy

Role: collaborator

NCT07495735Not Yet Recruiting

Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma

Role: lead

NCT07174947Phase 2Recruiting

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

Role: lead